3 completed. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow Ativan: new trials by email Literature Review of Ativan trials Research Report on Ativan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications Intramuscular route of active treatment, Intravenous route of active treatment - Status Epilepticus | Phase 3 | Completed | Robert Silbergleit | 1023 | 2009-06-01 | 2016-06-17 |
| Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2) lorazepam or diazepam - Status Epilepticus | Phase 2 / Phase 3 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 259 | 2008-02-01 | 2012-12-18 |
| Lorazepam Sedation for Critically Ill Children Lorazepam, Midazolam, Lorazepam CI - Critical Illness | Phase 2 / Phase 3 | Completed | The Emmes Company, LLC | 179 | 2004-09-01 | 2023-03-20 |
Status Epilepticus (2) · Critical Illness (1) · Seizures (1)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Robert Silbergleit (1) · The Emmes Company, LLC (1)
United States (3) · Canada (1)
Daniel H Lowenstein, MD (1) · James Chamberlain, MD (1) · Jeffrey L Blumer, MD, PhD (1) · Robert Silbergleit, MD (1) · Valerie L Durkalski, PhD (1)
PMID 21967361, PMID 22335736, PMID 22506949, PMID 24001080, PMID 24756515, PMID 27993298, PMID 35987977
U01NS056975 (1)